Central to both TERMINUS (biodegradable polymers, polymer compounding) and INTERfaces (biomaterials), covering formulation from concept to application.
BIOPOX SRL
Italian SME specializing in bio-based polymer formulation, smart additives, and enzyme-triggered systems for recyclable plastic packaging.
Their core work
BIOPOX is a Naples-based SME specializing in polymer formulation and bio-based material development. They work on designing biodegradable polymers, smart additives, and enzyme-triggered systems for plastic packaging recycling. Their applied chemistry expertise bridges the gap between laboratory biocatalysis and industrial polymer compounding, making them a formulation partner for projects that need to turn bio-based concepts into usable material products.
What they specialise in
TERMINUS specifically develops in-built triggered enzymes to recycle multi-layer packaging — a direct match to BIOPOX's polymer formulation capability.
TERMINUS targets PUR adhesives, multilayers, and smart additives for packaging applications.
INTERfaces (MSCA training network) focuses on heterogeneous biocatalytic reaction cascades and enzyme immobilization for biorefineries.
WASTE2FUELS addressed sustainable biofuel production from waste streams, an early entry into circular bioeconomy.
How they've shifted over time
BIOPOX entered H2020 through waste-to-energy work (WASTE2FUELS, 2016), focused on converting waste streams into biofuels. From 2019 onward, their focus shifted decisively toward bio-based polymers and enzymatic recycling of plastics, with TERMINUS and INTERfaces both centered on biocatalysis applied to materials. The trajectory shows a clear move from energy recovery to circular plastics — specifically enzyme-based approaches to making packaging recyclable or biodegradable.
BIOPOX is deepening into enzyme-enabled circular plastics, positioning themselves at the intersection of biocatalysis and polymer engineering — a space with growing regulatory and commercial demand in the EU.
How they like to work
BIOPOX always joins as a participant, never leading consortia — consistent with a specialist SME contributing formulation expertise to larger research efforts. With 53 unique partners across 16 countries from just 3 projects, they work in large, diverse consortia rather than small focused teams. This suggests they are comfortable operating in complex international projects and bring a defined, complementary skill set rather than competing for leadership.
Despite only 3 projects, BIOPOX has built a broad network of 53 partners across 16 countries, indicating participation in large European consortia. Their reach spans well beyond Italy, with significant pan-European connectivity for an SME of their size.
What sets them apart
BIOPOX sits at a rare intersection: they combine polymer formulation know-how with understanding of enzymatic and biocatalytic processes. Most polymer companies lack the biochemistry side; most biotech labs lack the compounding and formulation expertise. For any consortium working on bio-based or recyclable packaging, they offer the practical formulation bridge between enzyme science and a usable plastic product.
Highlights from their portfolio
- TERMINUSDirectly targets enzyme-triggered recycling of multi-layer packaging — their largest funded project (EUR 248K) and closest to their core polymer formulation identity.
- INTERfacesAn MSCA training network on biocatalytic cascades, signaling BIOPOX's investment in next-generation enzyme immobilization skills beyond their traditional polymer work.